BioLife Sciences Inc. Files Form 1-A with the Securities and Exchange Commission (SEC) to Raise Capital Under a Tier I Regulation A+ Offering
globenewswire.com
news
2022-06-01 21:45:00

HENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire â€“ BioLife Sciences Inc. (OTC: BLFE) (the 'Company' or 'BioLife'), announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier I Regulation A+ offering. The filing is structured to raise up to $20 million through the sale of our common stock at a price per share between $.05 and $.50. The final price will be set once the offering statement has been qualified by the SEC.
